Criteria | A N = 6 (40% of local PIs) | B N = 4 (26.67% of local PIs) | C N = 3 (20% of local PIs) | D N = 2 (13.33% of local PIs) | Total scores of Local Products N = 15 (42.86% of total PIs) | Total scores of Imported Products N = 20 (57.14% of total PIs) | Total N = 35 (100%) |
---|---|---|---|---|---|---|---|
Brand name | 6 (100%) | 4 (100) | 3 (100) | 2 (100) | 15 (100) | 20 (100) | 35 (100) |
Active ingredient | 6 (100) | 4 (100) | 3 (100) | 2 (100) | 15 (100) | 20 (100) | 35 (100) |
Inactive ingredients (excipients) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 1 (6.6) | 20 (100) | 21 (60) |
Therapeutic class | 2 (33.3) | 0 (0) | 2 (66.6) | 2 (100) | 6 (40) | 19 (95) | 25 (71.4) |
Mechanism of action | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 6 (30) | 6 (17.1) |
Indications | 6 (100) | 4 (100) | 3 (100) | 2 (100) | 15 (100) | 20 (100) | 35 (100) |
Drug dose | 0 (0) | 1 (25) | 1 (33.3) | 0 (0) | 2 (13.3) | 7 (35) | 9 (25.7) |
Duration of using | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (5) | 1 (2.8) |
Missing dose | 6 (100) | 2 (50) | 2 (66.6) | 2 (100) | 12 (80) | 17 (85) | 29 (82.8) |
Maximum dose | 0 (0) | 1 (25) | 1 (33.3) | 0 (0) | 2 (13.3) | 2 (10) | 4 (11.4) |
Directions for use | 6 (100) | 4 (100) | 3 (100) | 2 (100) | 15 (100) | 20 (100) | 35 (100) |
Overdose and management | 6 (100) | 2 (50) | 3 (100) | 2 (100) | 13 (86.6) | 20 (100) | 33 (94.2) |
Warning and precautions | 6 (100) | 4 (100) | 3 (100) | 2 (100) | 15 (100) | 19 (95) | 34 (97.1) |
Effect on ability to drive and use machines | 0 (0) | 1 (25) | 1 (33.3) | 1 (50) | 3 (20) | 20 (100) | 23 (65.7) |
Contraindications | 6 (100) | 2 (50) | 3 (100) | 2 (100) | 13 (86.6) | 20 (100) | 33 (94.2) |
Adverse drug reactions | 6 (100) | 4 (100) | 3 (100) | 2 (100) | 15 (100) | 20 (100) | 35 (100) |
Drug-drug interactions | 6 (100) | 4 (100) | 3 (100) | 2 (100) | 15 (100) | 20 (100) | 35 (100) |
Drug-food interactions | 1 (16.6) | 1 (25) | 1 (33.3) | 1 (50) | 4 (26.6) | 19 (95) | 23 (65.7) |
Pregnancy considerations | 6 (100) | 4 (100) | 3 (100) | 2 (100) | 15 (100) | 20 (100) | 35 (100) |
Lactation considerations | 6 (100) | 4 (100) | 3 (100) | 2 (100) | 15 (100) | 20 (100) | 35 (100) |
Pediatric considerations | 4 (66.6) | 3 (75) | 3 (100) | 2 (100) | 12 (80) | 20 (100) | 32 (91.4) |
Geriatric considerations | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 11 (55) | 11 (31.4) |
Possibility of tablet splitting | 0 (0) | 1 (25) | 0 (0) | 1 (50) | 2 (13.3) | 15 (75) | 17 (48.5) |
Possibility of crushing and mixing with food or beverages | 4 (66.6) | 3 (75) | 1 (33.3) | 1 (50) | 9 (60) | 15 (75) | 24 (68.5) |
Instructions to convert tablets or capsules into liquid forms | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Pharmacokinetic information | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (10) | 2 (5.7) |
Shelf life | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Storage | 6 (100) | 4 (100) | 3 (100) | 2 (100) | 15 (100) | 20 (100) | 35 (100) |
Name and address of manufacturers/distributors | 6 (100) | 4 (100) | 3 (100) | 2 (100) | 15 (100) | 19 (95) | 34 (97.1) |
Date of last revision | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 1 (6.6) | 14 (70) | 15 (42.8) |
Sources of information | 5 (83.3) | 2 (50) | 1 (33.3) | 0 (0) | 8 (53.3) | 0 (0) | 8 (22.8) |